Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acetyl-coenzyme A synthetase, cytoplasmic (ACSS2), is an enzyme that catalyzes the conversion of acetate into acetyl-CoA using ATP and CoA. This reaction is crucial for lipid synthesis, energy generation, and regulation of gene expression through histone acetylation. It is overexpressed in various cancers, promoting tumor growth and metastasis.
Inhibition of acetyl-CoA production from acetate
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acetyl-coenzyme A synthetase, cytoplasmic (ACSS2).